Get started
Author

Kimberly Aung

ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients
2015 · David Chu, Costanza Paoletti, et al. · Clinical Cancer Research · 181
Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer
2014 · Costanza Paoletti, Maria C. Muñiz, et al. · Clinical Cancer Research · 139
Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms
2017 · Costanza Paoletti, Andi K. Cani, et al. · Cancer Research · 106
Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
2015 · Costanza Paoletti, Yufeng Li, et al. · Clinical Cancer Research · 84
PDF
Engineering starch accumulation by manipulation of phosphate metabolism of starch
2012 · Sean E. Weise, Kimberly Aung, et al. · Plant Biotechnology Journal · 71
PDF
Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial
2018 · Costanza Paoletti, Gaia Schiavon, et al. · Clinical Cancer Research · 65
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance
2016 · Costanza Paoletti, Jose M. Larios, et al. · Molecular Oncology · 46
PDF
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients
2021 · Costanza Paoletti, Meredith M. Regan, et al. · npj Breast Cancer · 28
PDF
Serial monitoring of genomic alterations in circulating tumor cells of ER‐positive/HER2‐negative advanced breast cancer: feasibility of precision oncology biomarker detection
2021 · Andi K. Cani, Emily M. Dolce, et al. · Molecular Oncology · 21
PDF
Computed tomography (CT)-guided fiducial placement for lung nodule localization: a single-center experience
2026 · Katelyn R. Ward, Ryan Davis, et al. · Journal of Thoracic Disease
Implementation and Evaluation of a Simulation-Based Educational Intervention for Pediatric Chest Tube Management: A Quality Improvement Initiative
2026 · Ryan T. Davis, Spencer Wilhelm, et al. · Journal of Trauma Nursing
Prophylactic drainage does not appear to be necessary in robotic-assisted eTEP Rives–Stoppa, retro-rectus retromuscular hernia repair
2026 · Antonela Muca, Ibrahim Baida, et al. · International journal of abdominal wall and hernia surgery
Data from Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
2023 · Costanza Paoletti, Yufeng Li, et al.
Data from ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients
2023 · David Chu, Costanza Paoletti, et al.
SUPPLEMENTARY DATA from ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients
2023 · David Chu, Costanza Paoletti, et al.
PDF
Data from Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms
2023 · Costanza Paoletti, Andi K. Cani, et al.
Supplementary Data from Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms
2023 · Costanza Paoletti, Andi K. Cani, et al.
PDF
Supplementary Data from Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms
2023 · Costanza Paoletti, Andi K. Cani, et al.
Supplementary Figure 1-5 from Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
2023 · Costanza Paoletti, Yufeng Li, et al.
Supplementary Table 1 from Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
2023 · Costanza Paoletti, Yufeng Li, et al.
Supplementary Figures from Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer
2023 · Costanza Paoletti, Maria C. Muñiz, et al.
Supplementary Tables from Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer
2023 · Costanza Paoletti, Maria C. Muñiz, et al.
Supplementary Figures: Supplementary Figure 1.; Supplementary Figure 2.; Supplementary Tables: Supplementary Table 1.; Supplementary Table 2.; Supplementary Table 3.; Supplementary Table 4. from Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial
2023 · Costanza Paoletti, Gaia Schiavon, et al.
PDF
Data from Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer
2023 · Costanza Paoletti, Maria C. Muñiz, et al.
Data from Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial
2023 · Costanza Paoletti, Gaia Schiavon, et al.
Works count: 33
Citation count: 742
H-index: 9
I10-index: 9
Year
Topic
Type